NasdaqGM - Nasdaq Real Time Price USD
Fate Therapeutics, Inc. (FATE)
1.0500
+0.0500
+(4.98%)
As of 1:01:04 PM EDT. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 7 | 7 | 9 | 9 |
| Avg. Estimate | -0.38 | -0.38 | -1.46 | -1.25 |
| Low Estimate | -0.43 | -0.45 | -1.72 | -1.98 |
| High Estimate | -0.28 | -0.29 | -1.08 | -0.73 |
| Year Ago EPS | -0.47 | -0.33 | -1.64 | -1.46 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 9 | 9 | 10 | 9 |
| Avg. Estimate | 1.18M | 1.18M | 4.59M | 4.58M |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | 3.4M | 3.4M | 13.6M | 13.6M |
| Year Ago Sales | 1.93M | 6.77M | 13.63M | 4.59M |
| Sales Growth (year/est) | -38.47% | -82.56% | -66.32% | -0.22% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.45 | -0.45 | -0.41 | -0.42 |
| EPS Actual | -0.47 | -0.33 | -0.4 | -0.44 |
| Difference | -0.02 | 0.12 | 0.01 | -0.02 |
| Surprise % | -3.88% | 27.23% | 2.95% | -3.83% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.38 | -0.38 | -1.46 | -1.25 |
| 7 Days Ago | -0.39 | -0.4 | -1.52 | -1.29 |
| 30 Days Ago | -0.44 | -0.46 | -1.65 | -1.38 |
| 60 Days Ago | -0.46 | -0.46 | -1.63 | -1.23 |
| 90 Days Ago | -0.46 | -0.46 | -1.63 | -1.23 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 5 | 5 | 6 | 1 |
| Up Last 30 Days | 5 | 5 | 6 | 1 |
| Down Last 7 Days | -- | -- | 3 | 2 |
| Down Last 30 Days | -- | -- | 3 | 2 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| FATE | 19.27% | -16.58% | 11.10% | 14.58% |
| S&P 500 | 12.66% | 3.22% | 7.99% | 13.82% |
Upgrades & Downgrades
| Maintains | Stifel: Hold to Hold | 3/6/2025 |
| Reiterates | Wedbush: Neutral to Neutral | 3/6/2025 |
| Maintains | Wells Fargo: Equal-Weight to Equal-Weight | 3/6/2025 |
| Reiterates | Needham: Hold to Hold | 3/6/2025 |
| Reiterates | Needham: Hold | 11/19/2024 |
| Reiterates | Needham: Hold | 11/13/2024 |
Related Tickers
ALLO Allogene Therapeutics, Inc.
1.2000
0.00%
BEAM Beam Therapeutics Inc.
17.64
+8.71%
IPSC Century Therapeutics, Inc.
0.5207
-0.21%
CRBU Caribou Biosciences, Inc.
0.7971
+4.88%
PRME Prime Medicine, Inc.
1.3350
-5.99%
EDIT Editas Medicine, Inc.
1.4750
+10.87%
NTLA Intellia Therapeutics, Inc.
8.45
+15.84%
VERV Verve Therapeutics, Inc.
4.5400
+7.59%
AFMD Affimed N.V.
0.6975
+0.55%
IOVA Iovance Biotherapeutics, Inc.
3.2850
+4.95%